Get the Stockscreener App
18.15
2.84%
-0.53
After Hours:
17.72
-0.43
-2.37%
Erasca Inc stock is traded at $18.15, with a volume of 2.70M.
It is down -2.84% in the last 24 hours and down -0.93% over the past month.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Its focused RAS/MAPK pathway pipeline comprises modality-agnostic programs aligned with three therapeutic strategies of: targeting key upstream and downstream signaling nodes in the RAS/MAPK pathway; targeting RAS directly; and targeting escape routes that emerge in response to treatment. Its pipeline includes two clinical-stage programs (ERAS-0015, a pan-RAS molecular glue; and ERAS-4001, a pan-KRAS inhibitor), and ERAS-12, a discovery-stage program.
See More
Previous Close:
$18.68
Open:
$18.725
24h Volume:
2.70M
Relative Volume:
0.42
Market Cap:
$6.30B
Revenue:
-
Net Income/Loss:
$-277.02M
P/E Ratio:
-19.46
EPS:
-0.9328
Net Cash Flow:
$-91.36M
1W Performance:
-5.02%
1M Performance:
-0.93%
6M Performance:
+72.69%
1Y Performance:
+1,183%
1-Day Range:
$17.77
$18.92
1-Week Range:
$17.13
$19.96
52-Week Range:
$1.3301
$24.28
Erasca Inc Stock (ERAS) Company Profile
Name
Erasca Inc
Sector
Industry
Phone
(858) 465-6511
Address
3115 MERRYFIELD ROW, SAN DIEGO
Compare ERAS vs VRTX, REGN, ARGX, RVMD, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ERAS
Erasca Inc
|
18.15 | 6.55B | 0 | -277.02M | -91.36M | -0.9328 |
VRTX
Vertex Pharmaceuticals Inc
|
477.10 | 121.57B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
762.63 | 69.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
853.82 | 55.61B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
187.53 | 39.98B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
316.01 | 33.81B | 5.76B | 514.49M | 1.10B | 4.4813 |
Erasca Inc Stock (ERAS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-27-26 | Resumed | Mizuho | Outperform |
| Jan-07-26 | Initiated | Piper Sandler | Overweight |
| Oct-16-25 | Initiated | Stifel | Buy |
| Sep-03-25 | Downgrade | BofA Securities | Buy → Underperform |
| Aug-18-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Mar-26-25 | Initiated | Raymond James | Outperform |
| Nov-18-24 | Initiated | Jefferies | Buy |
| Mar-11-24 | Initiated | CapitalOne | Overweight |
| Jan-05-24 | Downgrade | BofA Securities | Buy → Neutral |
| Oct-11-23 | Initiated | H.C. Wainwright | Buy |
| Mar-30-23 | Initiated | Mizuho | Buy |
| Feb-24-23 | Initiated | Goldman | Buy |
| Feb-03-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
View All
Erasca Inc Stock (ERAS) Latest News
Bronstein, Gewirtz & Grossman LLC Urges Erasca, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire
Portnoy Law Firm Announces Class Action on Behalf of Erasca, Inc. Investors - GlobeNewswire
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of August 10, 2026 in Erasca, Inc. LawsuitERAS - PR Newswire
Notice to Long-Term Shareholders of Erasca, Inc. (NASDAQ: - GlobeNewswire
ERAS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review
ERAS INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Erasca, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire Inc.
ERASCA DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Erasca, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ERAS - GlobeNewswire Inc.
Erasca, Inc. Notice of August 10, 2026 Application Deadline for Class Action LawsuitContact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline - StreetInsider
ERAS Shareholder Alert: August 10, 2026 Lead Plaintiff - GlobeNewswire
Erasca Inc (ERAS) Cash Flow - TradingKey
Erasca Inc (ERAS) Income Statement - TradingKey
Erasca Inc (ERAS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Erasca Inc (ERAS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
AUGUST 10, 2026 INVESTOR DEADLINE: Erasca, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action LawsuitERAS - TMX Newsfile
Erasca Inc (ERAS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
2026-07-26 | ERAS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of Erasca, Inc. to Contact the Firm Today! | NDAQ:ERAS | Press Release - Stockhouse
Erasca Inc (ERAS) Valuation: PE, PB & Fair Value Analysis - TradingKey
August 10, 2026 Deadline Approaching: Join Class Action Against Erasca, Inc. (ERAS)Contact Levi & Korsinsky - ACCESS Newswire
Erasca Inc (ERAS) Institutional Confidence - TradingKey
Levi & Korsinsky Urges Erasca, Inc. (ERAS) Shareholders to Act Before Lead Plaintiff Deadline August 10, 2026 - ACCESS Newswire
Erasca Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against ErascaERAS - PR Newswire
ERASCA DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Erasca, Inc. Investors with Losses ... - Caledonian Record
ERAS Stock Slumps Nearly 40% After-Hours: Fine Print In 'Positive' Cancer Trial Reveals Treatment-Related Death - Stocktwits
Erasca, Inc. Revenue Breakdown – NASDAQ:ERAS - TradingView
Kaplan Fox Reminds Erasca, Inc. (ERAS) Investors Seeking Recovery of the Lead Plaintiff Deadline on August 10, 2026 - TMX Newsfile
ERAS INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Erasca, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Finansavisen
Bragar Eagel & Squire, P.C. Reminds Erasca, Inc. (ERAS) - GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Erasca, Inc. (ERAS) Investors that a Class Action ... - Caledonian Record
ERAS SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Erasca, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Deadline Alert: Erasca, Inc. (ERAS) Shareholders Who Lost - GlobeNewswire
ERAS Investors Have Opportunity to Lead Erasca, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire
Lost Money on Erasca, Inc. (ERAS)? Join Class Action Suit Seeking RecoveryContact SueWallSt - Finansavisen
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Erasca, Inc. of Class Action Lawsuit and Upcoming DeadlinesERAS - Finansavisen
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
2026-07-23 | ERAS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of Erasca, Inc. to Contact the Firm Today! | NDAQ:ERAS | Press Release - Stockhouse
ERAS Stockholders Have Opportunity to Lead Erasca, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
ERAS Investors Have Opportunity to Lead Erasca, Inc. Securities Fraud Lawsuit - Finansavisen
ERAS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Erasca, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
NASDAQ: ERAS CLASS ACTION NOTICE: Berger Montague Encourages Erasca, Inc. (NASDAQ: ERAS) Investors to Inquire About a Securities Fraud Class Action - Finansavisen
ERAS Deadline Alert: Levi & Korsinsky Reminds Erasca, Inc. (ERAS) Investors of Securities Class Action Deadline on August 10, 2026 - PR Newswire
ERASCA, INC. INVESTORS WITH LOSSES HAVE UNTIL AUGUST 10, - GlobeNewswire
Erasca investors face August 10 deadline in class action lawsuit - scanx.trade
ERAS INVESTOR DEADLINE: Erasca, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action LawsuitHBSS - Morningstar
Erasca (ERAS): Erasca Foundation files to sell 8,333 donated shares - Stock Titan
Kaplan Fox Announces a Securities Class Action Filed Against Erasca, Inc. (NASDAQ: ERAS)Lead Plaintiff Deadline is August 10, 2026 - The Globe and Mail
Erasca, Inc. (ERAS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - Morningstar
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Erasca, - GlobeNewswire
ERAS Deadline Alert: The Gross Law Firm Reminds Erasca, Inc. (ERAS) Investors of Securities Class Action Deadline on August 10, 2026 - PR Newswire
ERAS Maintained by Morgan Stanley -- Price Target Raised to $21 - GuruFocus
ERAS STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review
Erasca (ERAS) Faces Class Action Claims, Is 21% Below Fair Value Enough? - simplywall.st
Erasca Inc Stock (ERAS) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.44%
0.02%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):